FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136151285> ?p ?o ?g. }

• W3136151285 endingPage "606" @default.
• W3136151285 startingPage "598" @default.
• W3136151285 abstract "Background and Aims In July 2019, the fecal immunochemistry test (FIT) replaced the fecal occult blood test (FOBT) in England as the Bowel Cancer Screening Program (BCSP) screening tool. We aimed to assess the impact of this on healthcare resources at our BCSP center. Methods Two 6-month periods were initially analyzed for stool sample return and positivity rates. A subsequent comparative analysis of patient screening episodes assessed utilization of specialist screening practitioner (SSP) time, endoscopy, histology, radiology, surgical, and oncology service usage. Results A total of 42,234 patients received FOBT and 42,545 patients received FIT stool kits, with FIT showing higher return (61.8% vs 58.58%, FIT vs FOBT, P < .001) and sample positivity rates (2.41% vs 1.45%, FIT vs FOBT, P < .001). Four hundred patients commenced FOBT and 616 FIT screening episodes, a 54% increase. The FIT group had of a lower mean age (67.5 vs 69.5 years, FIT vs FOBT, P = .0001) with a lower nonattendance rate (.16% vs 1.5%, FIT vs FOBT, P = .01). With higher patient numbers, the FIT group required 69% more endoscopic procedures, 58% increased SSP time, 40% more radiologic tests, and 68% higher surgical procedures. FIT also led to a 109% increase in endoscopy-derived histology samples from an increase in the proportion of patients with polyps with FIT (54.8% vs 47.2%, P = .020) and a greater number of polyps per patient in whom polyps were found (3.00 vs 2.50 polyps, P = .017). This additional service burden equated to additional financial costs of approximately $558,000 per annum. Conclusions The implementation of FIT led to notable increases in SSP time, endoscopy procedures, radiology tests, surgical procedures, and histopathology services, resulting in considerable ongoing financial implications on the organization. Findings can be used to aid workforce and service planning in National Health Service sites delivering BCSP and countries that have already adopted or are considering FIT within their national screening programs. In July 2019, the fecal immunochemistry test (FIT) replaced the fecal occult blood test (FOBT) in England as the Bowel Cancer Screening Program (BCSP) screening tool. We aimed to assess the impact of this on healthcare resources at our BCSP center. Two 6-month periods were initially analyzed for stool sample return and positivity rates. A subsequent comparative analysis of patient screening episodes assessed utilization of specialist screening practitioner (SSP) time, endoscopy, histology, radiology, surgical, and oncology service usage. A total of 42,234 patients received FOBT and 42,545 patients received FIT stool kits, with FIT showing higher return (61.8% vs 58.58%, FIT vs FOBT, P < .001) and sample positivity rates (2.41% vs 1.45%, FIT vs FOBT, P < .001). Four hundred patients commenced FOBT and 616 FIT screening episodes, a 54% increase. The FIT group had of a lower mean age (67.5 vs 69.5 years, FIT vs FOBT, P = .0001) with a lower nonattendance rate (.16% vs 1.5%, FIT vs FOBT, P = .01). With higher patient numbers, the FIT group required 69% more endoscopic procedures, 58% increased SSP time, 40% more radiologic tests, and 68% higher surgical procedures. FIT also led to a 109% increase in endoscopy-derived histology samples from an increase in the proportion of patients with polyps with FIT (54.8% vs 47.2%, P = .020) and a greater number of polyps per patient in whom polyps were found (3.00 vs 2.50 polyps, P = .017). This additional service burden equated to additional financial costs of approximately $558,000 per annum. The implementation of FIT led to notable increases in SSP time, endoscopy procedures, radiology tests, surgical procedures, and histopathology services, resulting in considerable ongoing financial implications on the organization. Findings can be used to aid workforce and service planning in National Health Service sites delivering BCSP and countries that have already adopted or are considering FIT within their national screening programs." @default.
• W3136151285 created "2021-03-29" @default.
• W3136151285 creator A5004139513 @default.
• W3136151285 creator A5015513855 @default.
• W3136151285 creator A5027807300 @default.
• W3136151285 creator A5029427766 @default.
• W3136151285 creator A5050648068 @default.
• W3136151285 creator A5061176027 @default.
• W3136151285 creator A5069981206 @default.
• W3136151285 creator A5071569356 @default.
• W3136151285 creator A5072109228 @default.
• W3136151285 creator A5076174699 @default.
• W3136151285 creator A5078419083 @default.
• W3136151285 date "2021-09-01" @default.
• W3136151285 modified "2023-09-26" @default.
• W3136151285 title "Impact on healthcare resources of switch from fecal occult blood test to fecal immunochemical test within the English Bowel Cancer Screening Program: a single-center study" @default.
• W3136151285 cites W1489572165 @default.
• W3136151285 cites W1983396478 @default.
• W3136151285 cites W1990118688 @default.
• W3136151285 cites W2025927924 @default.
• W3136151285 cites W2034316060 @default.
• W3136151285 cites W2035552611 @default.
• W3136151285 cites W2046686567 @default.
• W3136151285 cites W2067246542 @default.
• W3136151285 cites W2068191747 @default.
• W3136151285 cites W2073314329 @default.
• W3136151285 cites W2074933207 @default.
• W3136151285 cites W2076728125 @default.
• W3136151285 cites W2097680546 @default.
• W3136151285 cites W2113414502 @default.
• W3136151285 cites W2118835794 @default.
• W3136151285 cites W2144595349 @default.
• W3136151285 cites W2145602937 @default.
• W3136151285 cites W2167981206 @default.
• W3136151285 cites W2255244114 @default.
• W3136151285 cites W2335868753 @default.
• W3136151285 cites W2411955921 @default.
• W3136151285 cites W2607160988 @default.
• W3136151285 cites W2617093818 @default.
• W3136151285 cites W2766319880 @default.
• W3136151285 cites W2888070246 @default.
• W3136151285 cites W2904985548 @default.
• W3136151285 cites W2907739634 @default.
• W3136151285 cites W2939021971 @default.
• W3136151285 cites W2947534203 @default.
• W3136151285 cites W2947923577 @default.
• W3136151285 cites W2968909179 @default.
• W3136151285 cites W2994685072 @default.
• W3136151285 cites W3006036209 @default.
• W3136151285 cites W3014205889 @default.
• W3136151285 doi "https://doi.org/10.1016/j.gie.2021.03.014" @default.
• W3136151285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33727015" @default.
• W3136151285 hasPublicationYear "2021" @default.
• W3136151285 type Work @default.
• W3136151285 sameAs 3136151285 @default.
• W3136151285 citedByCount "2" @default.
• W3136151285 countsByYear W31361512852021 @default.
• W3136151285 countsByYear W31361512852023 @default.
• W3136151285 crossrefType "journal-article" @default.
• W3136151285 hasAuthorship W3136151285A5004139513 @default.
• W3136151285 hasAuthorship W3136151285A5015513855 @default.
• W3136151285 hasAuthorship W3136151285A5027807300 @default.
• W3136151285 hasAuthorship W3136151285A5029427766 @default.
• W3136151285 hasAuthorship W3136151285A5050648068 @default.
• W3136151285 hasAuthorship W3136151285A5061176027 @default.
• W3136151285 hasAuthorship W3136151285A5069981206 @default.
• W3136151285 hasAuthorship W3136151285A5071569356 @default.
• W3136151285 hasAuthorship W3136151285A5072109228 @default.
• W3136151285 hasAuthorship W3136151285A5076174699 @default.
• W3136151285 hasAuthorship W3136151285A5078419083 @default.
• W3136151285 hasConcept C121608353 @default.
• W3136151285 hasConcept C126322002 @default.
• W3136151285 hasConcept C141071460 @default.
• W3136151285 hasConcept C142724271 @default.
• W3136151285 hasConcept C204787440 @default.
• W3136151285 hasConcept C2778435480 @default.
• W3136151285 hasConcept C2778451229 @default.
• W3136151285 hasConcept C2779158730 @default.
• W3136151285 hasConcept C520017518 @default.
• W3136151285 hasConcept C526805850 @default.
• W3136151285 hasConcept C71924100 @default.
• W3136151285 hasConcept C90924648 @default.
• W3136151285 hasConceptScore W3136151285C121608353 @default.
• W3136151285 hasConceptScore W3136151285C126322002 @default.
• W3136151285 hasConceptScore W3136151285C141071460 @default.
• W3136151285 hasConceptScore W3136151285C142724271 @default.
• W3136151285 hasConceptScore W3136151285C204787440 @default.
• W3136151285 hasConceptScore W3136151285C2778435480 @default.
• W3136151285 hasConceptScore W3136151285C2778451229 @default.
• W3136151285 hasConceptScore W3136151285C2779158730 @default.
• W3136151285 hasConceptScore W3136151285C520017518 @default.
• W3136151285 hasConceptScore W3136151285C526805850 @default.
• W3136151285 hasConceptScore W3136151285C71924100 @default.
• W3136151285 hasConceptScore W3136151285C90924648 @default.
• W3136151285 hasIssue "3" @default.
• W3136151285 hasLocation W31361512851 @default.
• W3136151285 hasOpenAccess W3136151285 @default.
• W3136151285 hasPrimaryLocation W31361512851 @default.

• next